Indication: ZIRGAN® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers)

Important Risk Information about ZIRGAN®

• ZIRGAN® is indicated for topical ophthalmic use only
• Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with ZIRGAN®
• Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%)
• Safety and efficacy in pediatric patients below the age of 2 years have not been established

Click here for ZIRGAN® prescribing information.